0001550379-15-000001.txt : 20150413 0001550379-15-000001.hdr.sgml : 20150413 20150413153518 ACCESSION NUMBER: 0001550379-15-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150413 DATE AS OF CHANGE: 20150413 EFFECTIVENESS DATE: 20150413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bell Biosystems, Inc. CENTRAL INDEX KEY: 0001550379 IRS NUMBER: 270415299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-209484 FILM NUMBER: 15766679 BUSINESS ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (703) 343-6477 MAIL ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D/A 1 primary_doc.xml X0707 D/A LIVE 0001550379 Bell Biosystems, Inc. 953 INDIANA STREET SAN FRANCISCO CA CALIFORNIA 94107 (703) 343-6477 DELAWARE None None Corporation true Bell, III B. Caleb c/o Bell Biosystems, Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Daniel Bell c/o Bell Biosystems, Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Stuart Berman c/o Bell Biosystems, Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Christian Olgaard c/o Bell Biosystems, Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Una Ryan c/o Bell Biosystems, Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Gil Van Bokkelen c/o Bell Biosystems, Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b true 0001550379-14-000002 2013-12-23 false true false 0 3810250 3810250 0 Series A Preferred Stock (Total Amount Sold includes conversion of Convertible Promissory Notes). false 25 0 0 0 false Bell Biosystems, Inc. /s/ Daniel Bell Daniel Bell Chief Financial Officer 2015-04-13